Oct. 28 - In this edition of Equity Forum, S&P Equity analyst Phillip Seligman notes that McKesson Corp. is a leading distributor of medical products and supplies and health care information technology products and services.
Beginning in FY 08 (Mar.), MCK started reporting its results in two segments: McKesson Distribution Solutions (MDS; 97.1% of FY 09 revenue on a pro forma basis) includes what was previously reported as Pharmaceutical Solutions and Medical-Surgical Solutions, with the exception of its Payor business. McKesson Technology Solutions (MTS; 2.9%) consists primarily of the former Provider Technologies segment and the aforementioned Payor business. He currently has a "5-Star" Strong Buy recommendation for McKesson Corp. (MCK).
